{Reference Type}: Journal Article
{Title}: The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization.
{Author}: Al Rahwanji MJ;Abouras H;Shammout MS;Altalla R;Al Sakaan R;Alhalabi N;Alhalabi M;Al Rahwanji MJ;Abouras H;Shammout MS;Altalla R;Al Sakaan R;Alhalabi N;Alhalabi M;
{Journal}: BMC Pregnancy Childbirth
{Volume}: 22
{Issue}: 1
{Year}: Mar 2022 7
{Factor}: 3.105
{DOI}: 10.1186/s12884-022-04412-9
{Abstract}: BACKGROUND: Our objective was to investigate the existence of an optimal period for oocyte retrieval in regards to the clinical pregnancy occurrence after the administration of recombinant human chorionic gonadotropin (rhCG) (Ovitrelle®).
METHODS: We studied the digital records of 3362 middle eastern couples who underwent in vitro fertilization (IVF) treatment between 2019 and 2021.
RESULTS: Through statistical testing, we found that there is a significant positive correlation between the oocyte retrieval period and the clinical pregnancy occurrence up to the 37th hour, where retrieval at the 37th hour was found to provide the most optimal outcome, especially in the case of gonadotropin-releasing hormone agonist (GnRHa) long protocol.
CONCLUSIONS: This cohort study recommends retrieval at hour 37 after ovulation triggering under the described conditions.